Hypochlorous acid (HOCl) is a powerful oxidant produced by activated phagocytes at sites of inflammation to kill a wide range of pathogens. Yet, it may also damage and kill the neighbouring host cells. The abundance of dead macrophages in atherosclerotic plaques and their colocalization with HOCl-modified proteins implicate HOCl may play a role in killing macrophages, contributing to disease progression. The first part of this research was to investigate the cytotoxic effect and cell death mechanism(s) of HOCl on macrophages. Macrophages require efficient defense mechanism(s) against HOCl to function properly at inflammatory sites. The second part of the thesis was to examine the antioxidative effects of glutathione (GSH) and 7,8-dihydroneopterin (7,8-NP) on HOCl-induced cellular damage in macrophages. GSH is an efficient scavenger of HOCl and a major intracellular antioxidant against oxidative stress, whereas 7,8-NP is secreted by human macrophages upon interferon-γ (IFN-γ) induction during inflammation and can also scavenge HOCl. HOCl caused concentration-dependent cell viability loss in human monocyte derived macrophage (HMDM) cells above a specific concentration threshold. HOCl reacted with HMDMs to cause viability loss within the first 10 minutes of treatment, and it posed no latent effect on the cells afterwards regardless of the HOCl concentrations. The lack of caspase-3 activation, rapid influx of propidium iodide (PI) dye, rapid loss of intracellular ATP and cell morphological changes (cell swelling, cell membrane integrity loss and rupture) were observed in HMDM cells treated with HOCl. These results indicate that HOCl caused HMDM cells to undergo necrotic cell death. In addition to the loss of intracellular ATP, HOCl also caused rapid loss of GAPDH enzymatic activity and mitochondrial membrane potential, indicating impairment of the metabolic energy production. Loss of the mitochondrial membrane potential was mediated by mitochondrial permeability transition (MPT), as blocking MPT pore formation using cyclosporin A (CSA) prevented mitochondrial membrane potential loss. HOCl caused an increase in cytosolic calcium ion (Ca2+) level, which was due to both intra- and extra-cellular sources. However, extracellular sources only contributed significantly above a certain HOCl concentration. Preventing cytosolic Ca2+ increase significantly inhibited HOCl-induced cell viability loss. This suggests that cytosolic Ca2+ increase was associated with HOCl-induced necrotic cell death in HMDM cells, possibly via the activation of Ca2+-dependent calpain cysteine proteases. Calpain inhibitors prevented HOCl-induced lysosomal destabilisation and cell viability loss in HMDM cells. Calpains induced HOCl-induced necrotic cell death possibly by degrading cytoskeletal and other cellular proteins, or causing the release of cathepsin proteases from ruptured lysosomes that also degraded cellular components. The HOCl-induced cytosolic Ca2+ increase also caused mitochondrial Ca2+ accumulation and MPT activation-mediated mitochondrial membrane potential loss. MPT activation, like calpain activation, was also associated with the HOCl-induced necrotic cell death, as preventing MPT activation completely inhibited HOCl-induced cell viability loss. The involvement of both calpain activation and MPT activation in HOCl-induced necrotic cell death in HMDM cells implies a cause and effect relationship between these two events. HMDM cells depleted of intracellular GSH using diethyl maleate showed increased susceptibility towards HOCl insult compared to HMDM cells with intact intracellular GSH levels, indicating that intracellular GSH played an important role in protecting HMDM cells against HOCl exposure. Intracellular GSH level in each HMDM cell preparation directly correlated with HOCl concentration required to kill 50% of population for each cell preparation, indicating intracellular GSH concentrations determine the efficiency of GSH in preventing HOCl-induced damage to HMDM cells. Intracellular GSH and cell viability loss induced by 400 μM HOCl were significantly prevented by 300 μM extracellular 7,8-NP, indicating that added 7,8-NP is an efficient scavenger of HOCl and out-competed intracellular GSH for HOCl. The amount of 7,8-NP synthesized by HMDM cells upon IFN-γ induction was too low to efficiently prevent HOCl-mediated intracellular GSH and cell viability loss. HOCl clearly causes HMDM cells to undergo necrosis when the concentration exceeds the intracellular GSH concentrations. Above this concentration HOCl causes oxidative damage to the Ca2+ ion channels on cell and ER membranes, resulting in an influx of Ca2+ ions into the cytosol and possibly the mitochondria. The rise in Ca2+ ions triggers calpain activation, resulting in the MPT-mediated loss of mitochondrial membrane potential, lysosomal instability and cellular necrosis.

Remyelination is a regenerative process that occurs through the formation of myelin sheaths by oligodendrocytes, which are recruited as oligodendrocyte progenitor cells (OPCs) after demyelination in diseases such as Multiple Sclerosis (MS).A key environmental factor regulating OPC differentiation is the fate of myelin debris generated during demyelination. Myelin debris contains inhibitors of OPC differentiation and thus its clearance by phagocytic macrophages is an important component of creating a lesion environment conducive to remyelination. The efficiency of debris clearance declines with age, contributing to the age-associated decline in remyelination. Therefore, understanding the mechanisms of the age-related decline in myelin debris phagocytosis is important for devising means to therapeutically reverse the decline in remyelination. The aim of this study was to determine the functional/molecular differences between young and old phagocytes involved in myelin debris clearance, thereby identifying therapeutically modifiable pathways associated with efficient myelin debris phagocytosis. In this study, we show that expression of genes involved in the retinoid X receptor (RXR) and peroxisome proliferator-activated receptor (PPAR) pathways are decreased with ageing in both myelin-phagocytosing human monocytes and mouse macrophages. Disruption of RXR and PPAR using synthetic antagonists in young macrophages mimics ageing by reducing myelin debris uptake. Macrophage-specific RXR? knockout mice revealed that loss of RXR function in young mice caused delayed myelin debris uptake and slowed remyelination. Alternatively, receptor agonists partially restored myelin debris phagocytosis in aged macrophages. The FDA-approved agonists bexarotene and pioglitazone, when used in concentrations achievable in human subjects, caused a reversion of the gene expression profiles in MS patient monocytes to a more youthful profile and enhanced myelin debris phagocytosis by patient cells. Activation of these pathways also enhances immunoregulatory markers on monocytes from MS patients, further suggesting the regeneration-promoting capacity of activating these pathways in phagocytes. These results reveal the RXR/PPAR pathway as a positive regulator of myelin debris clearance and a key player in the age-related decline in remyelination that may be targeted by available or newly-developed therapeutics.

Hypochlorous acid (HOCl) is a powerful oxidant produced by activated phagocytes at sites of inflammation to kill a wide range of pathogens. Yet, it may also damage and kill the neighbouring host cells. The abundance of dead macrophages in atherosclerotic plaques and their colocalization with HOCl-modified proteins implicate HOCl may play a role in killing macrophages, contributing to disease progression. The first part of this research was to investigate the cytotoxic effect and cell death mechanism(s) of HOCl on macrophages. Macrophages require efficient defense mechanism(s) against HOCl to function properly at inflammatory sites. The second part of the thesis was to examine the antioxidative effects of glutathione (GSH) and 7,8-dihydroneopterin (7,8-NP) on HOCl-induced cellular damage in macrophages. GSH is an efficient scavenger of HOCl and a major intracellular antioxidant against oxidative stress, whereas 7,8-NP is secreted by human macrophages upon interferon-γ (IFN-γ) induction during inflammation and can also scavenge HOCl. HOCl caused concentration-dependent cell viability loss in human monocyte derived macrophage (HMDM) cells above a specific concentration threshold. HOCl reacted with HMDMs to cause viability loss within the first 10 minutes of treatment, and it posed no latent effect on the cells afterwards regardless of the HOCl concentrations. The lack of caspase-3 activation, rapid influx of propidium iodide (PI) dye, rapid loss of intracellular ATP and cell morphological changes (cell swelling, cell membrane integrity loss and rupture) were observed in HMDM cells treated with HOCl. These results indicate that HOCl caused HMDM cells to undergo necrotic cell death. In addition to the loss of intracellular ATP, HOCl also caused rapid loss of GAPDH enzymatic activity and mitochondrial membrane potential, indicating impairment of the metabolic energy production. Loss of the mitochondrial membrane potential was mediated by mitochondrial permeability transition (MPT), as blocking MPT pore formation using cyclosporin A (CSA) prevented mitochondrial membrane potential loss. HOCl caused an increase in cytosolic calcium ion (Ca2+) level, which was due to both intra- and extra-cellular sources. However, extracellular sources only contributed significantly above a certain HOCl concentration. Preventing cytosolic Ca2+ increase significantly inhibited HOCl-induced cell viability loss. This suggests that cytosolic Ca2+ increase was associated with HOCl-induced necrotic cell death in HMDM cells, possibly via the activation of Ca2+-dependent calpain cysteine proteases. Calpain inhibitors prevented HOCl-induced lysosomal destabilisation and cell viability loss in HMDM cells. Calpains induced HOCl-induced necrotic cell death possibly by degrading cytoskeletal and other cellular proteins, or causing the release of cathepsin proteases from ruptured lysosomes that also degraded cellular components. The HOCl-induced cytosolic Ca2+ increase also caused mitochondrial Ca2+ accumulation and MPT activation-mediated mitochondrial membrane potential loss. MPT activation, like calpain activation, was also associated with the HOCl-induced necrotic cell death, as preventing MPT activation completely inhibited HOCl-induced cell viability loss. The involvement of both calpain activation and MPT activation in HOCl-induced necrotic cell death in HMDM cells implies a cause and effect relationship between these two events. HMDM cells depleted of intracellular GSH using diethyl maleate showed increased susceptibility towards HOCl insult compared to HMDM cells with intact intracellular GSH levels, indicating that intracellular GSH played an important role in protecting HMDM cells against HOCl exposure. Intracellular GSH level in each HMDM cell preparation directly correlated with HOCl concentration required to kill 50% of population for each cell preparation, indicating intracellular GSH concentrations determine the efficiency of GSH in preventing HOCl-induced damage to HMDM cells. Intracellular GSH and cell viability loss induced by 400 μM HOCl were significantly prevented by 300 μM extracellular 7,8-NP, indicating that added 7,8-NP is an efficient scavenger of HOCl and out-competed intracellular GSH for HOCl. The amount of 7,8-NP synthesized by HMDM cells upon IFN-γ induction was too low to efficiently prevent HOCl-mediated intracellular GSH and cell viability loss. HOCl clearly causes HMDM cells to undergo necrosis when the concentration exceeds the intracellular GSH concentrations. Above this concentration HOCl causes oxidative damage to the Ca2+ ion channels on cell and ER membranes, resulting in an influx of Ca2+ ions into the cytosol and possibly the mitochondria. The rise in Ca2+ ions triggers calpain activation, resulting in the MPT-mediated loss of mitochondrial membrane potential, lysosomal instability and cellular necrosis.

Les coxsackievirus du groupe B (CVB) sont des petits virus à ARN appartenant à au genre Enterovirus et à la famille des Picornaviridae. Chez, l’homme, les CVB sont responsables de nombreuses infections aiguës bénignes ou sévères. Ils sont également incriminés dans le développement de maladies chroniques telles que le diabète de type 1 (DT1). En effet, plusieurs données épidémio-cliniques sont en faveur d’un lien entre les entérovirus et notamment les CVB et le DT1. Deux mécanismes majeurs ont été proposés pour expliquer cette pathogenèse entérovirale du DT1. Il s’agit de l’activation « en passant » d’un environnement inflammatoire et la persistance virale qui concourent à l’initiation du processus auto-immun. Les études présentées dans cette thèse visent à comprendre les caractéristiques et conséquences de l’infection à CVB qui pourraient expliquer l’implication de ces mécanismes. Les résultats obtenus suggèrent que CVB4 (utilisé comme modèle des CVB) est un virus inflammatoire. In vitro, il induit la production de grandes quantités d’IFNα par les cellules mononuclées du sang (CMN). Néanmoins cette induction d’IFNα n’est possible qu’en cas de facilitation de l’infection par des anticorps non neutralisants, qui se traduit par une entrée importante du virus dans les cellules. Dans nos travaux, l’IFNα a été détecté dans le plasma de sujets diabétiques, et fréquemment associé à la présence d’ARN entéroviral. De même, parmi les CMN, les monocytes ont été identifiés comme les principales cellules cibles du virus. En dehors de l’IFNα, nous avons montré que CVB4 peut induire la synthèse de plusieurs autres cytokines pro-inflammatoires notamment l’IL-6 et le TNFα. De façon intéressante, l’infection des cellules n’est pas indispensable car cette induction est possible par des particules non infectieuses. Cette production de cytokines pro-inflammatoires par les CMN peut également être amplifiée par la facilitation de l’infection en présence de particules infectieuses de CVB4. Nous avons montré que les macrophages, cellules effectrices importantes de l’immunité innée au niveau tissulaire, peuvent produire en présence de CVB4 de l’IFNα et d’autres cytokines pro-inflammatoires. Les macrophages dérivés de CMN en présence de M-CSF (mais pas de GM-CSF) sont infectables par CVB4 et le virus peut persister dans ces cellules. CVB4 peut également établir une infection chronique productive de type « état porteur » dans des cellules canalaires pancréatiques. Les cellules chroniquement infectées peuvent être guéries grâce à un traitement par de la fluoxétine. Cette molécule utilisée dans le traitement de troubles psychiatriques, présente in vitro une activité antivirale vis-à-vis de certains entérovirus, et permet d’éliminer complètement en quelques semaines le virus des cellules chroniquement infectées par CVB4. Des modifications cellulaires ont été observées au niveau des cellules chroniquement infectées notamment une diminution de l’expression de PDX-1, une résistance à la lyse au cours d’une réinfection par CVB4, ainsi qu’une diminution très importante de l’expression du récepteur CAR. Ces modifications cellulaires acquises au cours de l’infection chronique pouvaient persister après l’élimination du virus. Les cellules chroniquement infectées présentent également un profil de microARNs très différent de celui des cellules non infectées. Une évolution du virus a été également observée avec des changements phénotypiques et génotypiques. L’ensemble de nos observations montre que les caractéristiques de l’infection à CVB4 sont compatibles avec les mécanismes évoqués dans la pathogenèse entérovirale du DT1 et renforcent l’hypothèse de l’implication des CVB dans cette maladie. / Group B coxsackieviruses (CVB) are small RNA viruses belonging to Enterovirus genus and to the Picornaviridae family. In humans, CVB can cause numerous mild and severe acute infections. They are also thought to be involved in the development of chronic diseases such as type 1 diabetes (T1D). Several epidemiological and clinical data support a link between enteroviruses, especially CVB and T1D. Two main mechanisms have been described to explain this enteroviral pathogenesis of T1D including a “bystander activation” of an inflammatory environment and viral persistence. These mechanisms contribute to initiation of the autoimmune process. Our studies aimed to understand the features and outcomes of CVB infection that could explain their involvement in these mechanisms. The results suggest that CVB4 (used as CVB model) is an inflammatory virus. CVB4 induces in vitro the production by peripheral blood mononuclear cells (PBMCs) of high amounts of IFNα. However this induction is only possible when CVB4 infection is enhanced by non-neutralizing antibodies, resulting in increased viral entry in cells. We also reported detection of IFNα in plasma of T1D patients, commonly associated with enteroviral RNA. In addition, monocytes have been identified as major targets of enteroviruses among PBMCs. Besides IFNα, CVB4 can induce the synthesis of other proinflammatory cytokines, mainly IL-6 and TNFα. Interestingly, infection is not needed, since inactivated viral particles can induce these proinflammatory cytokines. In addition, the enhancing of CVB4 infection in PBMCs results in increased production of these cytokines. We have shown that macrophages that are known as major innate immunity effectors can produce IFNα and other proinflammatory cytokines upon infection with CVB4. Macrophages derived from PBMCs in presence of M-CSF (but not GM-CSF) can be infected by CVB4, and the virus can persist in these cells. CVB4 can also establish a productive, carrier-sate persistent infection in pancreatic ductal-like cells. The virus can be completely cleared from chronically-infected cells using fluoxetine. This molecule already used in the treatment of depression and other mental disorders, has displayed antiviral activity against many enteroviruses, and can completely clear CVB4 from chronically-infected cells within few weeks. Cellular changes have been observed during chronic infection including a reduced expression of PDX-1, a resistant profile to lysis upon superinfection with CVB4, and an important decrease of CAR expression. These changes can linger even after the clearance of CVB4. In addition the miRNA profile in chronically-infected ductal-like cells was clearly different from that of mock-infected cells. Some phenotypic and genotypic changes were also observed in the virus derived from chronic infection. Altogether, these findings show the features of CVB4 infection are compatible with mechanisms reported in the enteroviral pathogenesis of T1D, and support the hypothesis of involvement of CVB in this disease.

La réponse immunitaire est régulée spatialement et temporellement. Les cellules immunitaires font partie d’une plus grande communauté de populations cellulaires interconnectées qui coordonnent leurs actions par la signalisation intercellulaire. Suivant une blessure hépatique, la distribution et la composition du compartiment immunitaire évoluent rapidement au fil du temps. Par conséquent, l’information sur la position des cellules immunitaires dans le tissu hépatique est essentielle à la bonne compréhension de leurs fonctions dans la santé et la maladie. Cependant, l’organisation spatiale des cellules immunitaires en réponse à une atteinte hépatique aiguë, ainsi que les conséquences fonctionnelles de leur distribution topographique spécifique, restent mal comprises. Les macrophages hépatiques sont des cellules effectrices clés pendant l’homéostasie et en réponse à des blessures, et sont impliqués dans la pathogenèse de plusieurs maladies du foie. L’hétérogénéité et plasticité des macrophages dans le foie a été exposée avec l’émergence du séquençage de l’ARN, la cytométrie en flux et la cytométrie de masse. Ces techniques ont sensiblement contribué à la compréhension de l’origine, et fonctions des macrophages dans le foie. Cependant, ces technologies impliquent la destruction du tissu pour la préparation de suspension cellulaires ce qui entraîne une perte d’information spatiale et de contexte tissulaire. Par conséquent, la caractérisation spatiale et temporelle des macrophages dans le tissu hépatique pendant l’homéostasie tissulaire, et en réponse à une blessure, fournit une nouvelle information sur la façon dont les macrophages se rapportent aux cellules voisines et leur comportement pendant les réponses immunitaires. Dans la première partie de cette étude, nous avons conçu une stratégie pour le phénotypage spatial des cellules immunitaires hépatiques dans des échantillons de tissus. Cette stratégie combine techniques d'imagerie et l’alignement numérique des images pour surmonter les limitations actuelles du nombre de marqueurs pouvant être visualisés simultanément. En outre, nous avons généré des protocoles pour la quantification automatisée des cellules d’intérêt dans des sections de tissus pour réduire la subjectivité associée à la quantification par inspection visuelle, et pour augmenter la surface et la vitesse de l’analyse. Par conséquent, un plus grand nombre de populations de cellules immunitaires ont été visualisées, quantifiées et cartographiées, et leurs relations spatiales ont été déterminées. Dans la deuxième partie de l’étude, nous avons déterminé la cinétique et la dynamique spatiale des cellules de Kupffer (KCs) et des macrophages dérivés de monocytes (MoMFs) en réponse à une atteinte hépatique aiguë au CCl4, afin de mieux comprendre leurs rôles fonctionnels, et la répartition du travail entre eux. Nous avons constaté que les KC et les MoMFs présentent des différences au niveau de la distribution tissulaire, la morphologie, et la cinétique. En plus, seulement les KCs ont proliféré pour repeupler la population de macrophages résidents pendant la réparation tissulaire. Finalement, nous avons montré que le degré de colocalization de KCs et des MoMFs avec les cellules stellaires est différent. En plus, cette colocalisation varie avec la progression de la réponse immunitaire. Dans l’ensemble, nous avons montré que les KCs et les MoMFs ont des profils spatiaux et temporels différents en réponse à une atteinte hépatique aiguë. Dans l’ensemble, les observations faites dans cette étude suggèrent que le comportement spatial et temporel d’une sous-population donnée de cellules immunitaires est distinct et sous-tend sa capacité à remplir ses fonctions spécifiques pendant la réponse immunitaire. / The immune response is spatially and temporally regulated. Immune cells are part of a larger community of interconnected immune and non-immune cell populations that coordinate their actions mostly through cell-cell intercellular signaling. In the liver, the distribution pattern, and the composition of the immune compartment evolve during an immune response to injury influencing disease pathology, progression, and response to treatment. Hence, information on the location and interacting partners of immune cells in the hepatic tissue is critical for the proper understanding of their functions in health and disease. However, the spatial organization of hepatic resident and infiltrating immune cells in response to acute injury, and the functional consequences of their specific topographical distribution, remain poorly defined. Hepatic macrophages are key effector cells during homeostasis and in response to injury and are involved in the pathogenesis of several liver diseases. The heterogeneity and plasticity of the macrophage compartment in the liver have only recently started to be appreciated with the emergence of RNA sequencing, flow cytometry, and mass cytometry. Detailed transcriptomic and phenotypic profiling have deeply expanded our understanding of macrophage biology. However, these technologies involve tissue disruption with loss of spatial information and tissue context. Therefore, the spatial and temporal profiling of liver macrophages in tissue samples during the steady state, and in response to injury, provide novel information on how the macrophages relate to neighboring cells and their behavior during immune responses. In the first part of this study, we designed a strategy for the spatial phenotyping of hepatic immune cells in tissue samples. This strategy combined serial and sequential labeling, and digital tissue alignment to overcome current limitations in the number of markers that can be simultaneously visualized. In addition, we generated protocols for automated quantification of cells of interest in whole tissue sections which removed the subjectivity associated with quantification by visual inspection and greatly increased the area and the speed of the analysis. As a result, a larger number of immune cell populations were visualized, quantified, and mapped, and their spatial relations were determined in an unbiased manner. In the second part of this study, we monitored the kinetics, and spatial dynamics of resident Kupffer cells (KCs) and infiltrating monocyte-derived macrophages (MoMFs) in response to acute liver injury with CCl4, to gain insight into their functional roles, and the distribution of labor between them. KCs and MoMFs exhibited different tissue distribution patterns and cell morphology, different kinetics, and occupied neighboring but unique microanatomical tissue locations. KCs and MoMFs displayed a different capacity to replenish the macrophage pool upon acute injury, and were differentially related to hepatic stellate cells. Different kinetics and spatial profiles revealed that KCs and MoMFs have distinct spatial signatures and suggest that they perform distinct functions during the wound-healing response to acute liver injury. In summary, we optimized techniques and put together a strategy for the spatial profiling of hepatic immune cells. Then, we used this methodology to profile resident and infiltrating macrophage subpopulations to gain insight into their biology and distinct contribution to healing in response to acute liver injury. Overall, the observations made in this study suggest that the spatial and temporal behavior of a given subpopulation of immune cells underlie its ability to perform its specific functions during the immune response.